SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-021440
Filing Date
2024-02-27
Accepted
2024-02-27 17:33:53
Documents
2
Period of Report
2024-02-26

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1611
2 EX-24 iron-ex24.htm EX-24 13679
  Complete submission text file 0000950170-24-021440.txt   16944
Mailing Address C/O ZYNERBA PHARMACEUTICALS, INC. 80 W. LANCASTER AVENUE, SUITE 300 DEVON PA 19333
Business Address
Stephenson Pamela (Reporting) CIK: 0001767650 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39438 | Film No.: 24688814

Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Issuer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)